Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SELLAS Life Sciences (SLS) Amortization of Deferred Charges (2021)

SELLAS Life Sciences (SLS) has disclosed Amortization of Deferred Charges for 1 consecutive years, with $846000.0 as the latest value for Q1 2021.

  • On a quarterly basis, Amortization of Deferred Charges changed N/A to $846000.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $846000.0, a N/A change, with the full-year FY2020 number at $282000.0, changed N/A from a year prior.
  • Amortization of Deferred Charges was $846000.0 for Q1 2021 at SELLAS Life Sciences.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $846000.0 in Q1 2021 to a low of $846000.0 in Q1 2021.